GAIN THERAPEUTICS INC. - COMMON STOCK

Gain Therapeutics Appoints Matthias Alder as Chief Operating Officer

19 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at the Cantor Virtual Global Healthcare Conference

23 Sep 2021 08:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

17 Sep 2021 08:00:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at 2021 International Virtual GM1 Community Conference

09 Sep 2021 16:20:04 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson’s Disease

08 Sep 2021 09:08:54 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson’s Disease

08 Sep 2021 07:29:00 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

02 Sep 2021 16:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports Second Quarter 2021 Financial Results and Business Update

11 Aug 2021 16:01:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at the BTIG Virtual Biotechnology Conference

03 Aug 2021 16:05:02 By Nasdaq GlobeNewswire

Gain Therapeutics Announces Issuance of Two New PCT Patents Covering GBA and GALC Modulator Compounds for Treatment of CNS Disorders

10 Jun 2021 07:30:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at the Jefferies Virtual Healthcare Conference

27 May 2021 08:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate in Upcoming Virtual Investor Conferences in May

17 May 2021 08:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports First Quarter 2021 Financial Results

10 May 2021 16:01:00 By Nasdaq GlobeNewswire

Gain Therapeutics Presents Positive In Vitro & In Vivo Data on Its Orally Bioavailable Brain Penetrant Star Compounds for the Treatment of GBA1 Parkinson’s Disease & Related α-synucleopathies at the XXVI IAPRD World Congress

03 May 2021 07:30:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at the B. Riley Securities’ Virtual Neuroscience Conference

27 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

Gain Therapeutics Announces Presentation at the International Association of Parkinsonism and Related Disorders 2021 World Congress

22 Apr 2021 08:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals

20 Apr 2021 08:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option to Purchase Additional Shares

25 Mar 2021 17:57:22 By Nasdaq GlobeNewswire